The content on this site is intended for healthcare professionals only
Dr Fernandez speaks with ecancer about industry collaboration in the HARMONY project.
He highlights the valuable contribution possible through the project, which brings together 51 partners from 11 European countries, including 7 pharmaceutical companies, and puts emphasis on improving patient access to trials.
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
The 5-year long-term outcomes of radiation technique for locally advanced NSCLC
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
